Page last updated: 2024-11-03

probenecid and Eosinophilia

probenecid has been researched along with Eosinophilia in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.

Research Excerpts

ExcerptRelevanceReference
"Hematuria and eosinophilia developed in two patients being treated for bacterial endocarditis with 20 or 24 gm/day of cephalexin given orally together with probenecid (Benemid)."3.65Cephalexin-related nephropathy. ( Kieff, E; Verma, S, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verma, S1
Kieff, E1

Other Studies

1 other study available for probenecid and Eosinophilia

ArticleYear
Cephalexin-related nephropathy.
    JAMA, 1975, Nov-10, Volume: 234, Issue:6

    Topics: Administration, Oral; Adult; Cephalexin; Drug Hypersensitivity; Endocarditis; Eosinophilia; Hematuri

1975